EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
EPRS was delisted on the 3rd of August, 2016.
45 hedge funds and large institutions have $41.3M invested in EPIRUS BIOPHARMACEUTICALS INC COM in 2015 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 6 closing their positions.
114% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 7
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
10% more funds holding
Funds holding: 41 → 45 (+4)
36% less capital invested
Capital invested by funds: $64.9M → $41.3M (-$23.6M)
99% less call options, than puts
Call options by funds: $3K | Put options by funds: $388K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
+$2.7M |
| 2 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$1.98M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.13M |
| 4 |
SIM
Spark Investment Management
New York
|
+$423K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$318K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$10.3M |
| 2 |
B
Bailard
Foster City,
California
|
-$1.56M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$355K |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$254K |
| 5 |
JCG
JHL Capital Group
Chicago,
Illinois
|
-$243K |
EPRS Hedge Fund Activity: Q4 2015 in Review
45 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) for Q4 2015, worth a combined $41.3M — down 36% from $64.9M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new EPRS positions and 6 closed out — a net gain of 4 holders — while 15 added to existing stakes and 7 trimmed.
The largest buyer was Broadfin Capital, adding an estimated $2.7M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $10.3M sold.
- 45 institutional investors held EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) as of Q4 2015, up from 41 in Q3 2015.
- Funds reported $41.3M of EPIRUS BIOPHARMACEUTICALS INC COM stock for Q4 2015, down 36% quarter-over-quarter.
- 10 funds opened new EPIRUS BIOPHARMACEUTICALS INC COM positions in Q4 2015 and 6 closed out, a net change of +4 holders.
- The largest EPIRUS BIOPHARMACEUTICALS INC COM buyer in Q4 2015 was Broadfin Capital, an estimated $2.7M added.
- The largest EPIRUS BIOPHARMACEUTICALS INC COM seller in Q4 2015 was Consonance Capital Management, an estimated $10.3M sold.
Based on aggregated 13F filings for Q4 2015.